Accounts Receivable, after Allowance for Credit Loss, Current of Zeo ScientifiX, Inc. from 31 Oct 2015 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Zeo ScientifiX, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Oct 2015 to 31 Oct 2025.
  • Zeo ScientifiX, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Oct 2025 was $35,000, a 82% decline year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Zeo ScientifiX, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $35,000 -$159,000 -82% 31 Oct 2025 10-K 29 Jan 2026 2024 FY
Q1 2025 $11,000 -$49,000 -82% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $6,000 -$71,000 -92% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $194,000 +$176,000 +978% 31 Oct 2024 10-K 29 Jan 2026 2024 FY
Q2 2024 $19,000 -$1,762 -8.5% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $60,000 +$47,020 +362% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $77,000 -$29,895 -28% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $18,000 -$37,110 -67% 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $20,762 -$105,741 -84% 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $12,980 -$35,201 -73% 30 Apr 2023 10-Q 16 Jun 2023 2023 Q2
Q4 2022 $106,895 -$7,118 -6.2% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $55,110 -$49,040 -47% 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $126,503 +$78,278 +162% 31 Jul 2022 10-Q 14 Sep 2022 2022 Q3
Q1 2022 $48,181 -$29,994 -38% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q2
Q4 2021 $114,013 +$54,723 +92% 31 Jan 2022 10-Q 16 Mar 2022 2022 Q1
Q3 2021 $104,150 +$74,765 +254% 31 Oct 2021 10-K 14 Feb 2023 2022 FY
Q2 2021 $48,225 -$19,590 -29% 31 Jul 2021 10-Q 14 Sep 2021 2021 Q3
Q1 2021 $78,175 +$40,250 +106% 30 Apr 2021 10-Q 14 Jun 2021 2021 Q2
Q4 2020 $59,290 -$4,275 -6.7% 31 Jan 2021 10-Q 17 Mar 2021 2021 Q1
Q3 2020 $29,385 +$3,354 +13% 31 Oct 2020 10-K 14 Feb 2022 2021 FY
Q2 2020 $67,815 +$5,409 +8.7% 31 Jul 2020 10-Q 18 Dec 2020 2020 Q3
Q1 2020 $37,925 +$7,795 +26% 30 Apr 2020 10-Q 17 Dec 2020 2020 Q2
Q4 2019 $63,565 +$36,985 +139% 31 Jan 2020 10-Q 17 Dec 2020 2020 Q1
Q3 2019 $26,031 -$21,994 -46% 31 Oct 2019 10-K 08 Feb 2021 2020 FY
Q2 2019 $62,406 +$140 +0.22% 31 Jul 2019 10-Q 16 Oct 2020 2019 Q3
Q1 2019 $30,130 -$62,462 -67% 30 Apr 2019 10-Q 16 Oct 2020 2019 Q2
Q4 2018 $26,580 -$109,559 -80% 31 Jan 2019 10-Q 16 Oct 2020 2019 Q1
Q3 2018 $48,025 -$59,270 -55% 31 Oct 2018 10-K 16 Oct 2020 2019 FY
Q2 2018 $62,266 -$70,794 -53% 31 Jul 2018 10-Q 06 Mar 2020 2018 Q3
Q1 2018 $92,592 +$10,287 +12% 30 Apr 2018 10-Q 06 Mar 2020 2018 Q2
Q4 2017 $136,139 31 Jan 2018 10-Q 06 Mar 2020 2018 Q1
Q3 2017 $107,295 +$106,170 +9437% 31 Oct 2017 10-K 06 Mar 2020 2018 FY
Q2 2017 $133,060 +$132,977 31 Jul 2017 10-Q 19 Sep 2017 2017 Q3
Q1 2017 $82,305 +$82,223 30 Apr 2017 10-Q 14 Jul 2017 2017 Q2
Q3 2016 $1,125 -$18,753 -94% 31 Oct 2016 10-K 01 Nov 2018 2017 FY
Q2 2016 $83* 31 Jul 2016 10-Q 26 Oct 2016 2016 Q3
Q1 2016 $82* 30 Apr 2016 10-Q 22 Aug 2016 2016 Q2
Q3 2015 $19,878 31 Oct 2015 10-K 07 Jul 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.